Lymphoblastic Leukemia, Acute, Childhood Completed Phase 1 Trials for Quizartinib (DB12874)

IndicationStatusPhase
DBCOND0044925 (Lymphoblastic Leukemia, Acute, Childhood)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs